Abstract
In groups of 16 patients with multiple sclerosis, 13 months' double-blind treatment with transfer factor from random normal donors differed from placebo treatment only in producing a temporary restoration of lymphocyte reactivity to measles virus antigen, and did not arrest the degeneration of nerve tissue.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Antigens, Viral
-
Clinical Trials as Topic
-
Double-Blind Method
-
Evaluation Studies as Topic
-
Female
-
Humans
-
Injections, Subcutaneous
-
Lymphocyte Activation
-
Lymphocytes / immunology
-
Male
-
Measles virus / immunology
-
Middle Aged
-
Multiple Sclerosis / immunology
-
Multiple Sclerosis / therapy*
-
Time Factors
-
Transfer Factor / administration & dosage*
-
Transfer Factor / therapeutic use
Substances
-
Antigens, Viral
-
Transfer Factor